Could a common breast cancer pill stop uterine Cancer's return?
NCT ID NCT05454358
Summary
This study tested whether taking the hormone-blocking drug letrozole for two years after standard surgery and treatment could help prevent endometrial (uterine) cancer from returning. It compared letrozole against just watching and waiting (observation) in patients with a specific, common type of this cancer who were at intermediate or high risk of it coming back. The trial was stopped early and enrolled only 12 patients, so its results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.